Increased infectivity in human cells and resistance to antibody-mediated neutralization by truncation of the SIV gp41 cytoplasmic tail

Frontiers in Microbiology

Volumn 4, Issue MAY, 2013, Pages

  Kuwata, Takeo ^a   Takaki, Kaori ^a   Enomoto, Ikumi ^a   Yoshimura, Kazuhisa ^b   Matsushita, Shuzo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Antibody; Gp41; Infectivity; Neutralization; Resistance; SIV; Truncation

Indexed keywords

GLYCOPROTEIN GP 41; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B404; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY MEDIATED NEUTRALIZATION; ARTICLE; CELL MEMBRANE RESISTANCE; CONTROLLED STUDY; DNA EXTRACTION; FLOW CYTOMETRY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; NUCLEOTIDE SEQUENCE; POINT MUTATION; SERODIAGNOSIS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VIRUS INFECTIVITY; VIRUS REPLICATION; VIRUS STRAIN; WESTERN BLOTTING;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84884219942     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2013.00117     Document Type: Article

References (32)

1. Akari, H., Nam, K. H., Mori, K., Otani, I., Shibata, H., Adachi, A., et al. (1999). Effects of SIVmac infection on peripheral blood CD4+CD8+ T lymphocytes in cynomolgus macaques. Clin. Immunol. 91, 321-329.
2. Berlioz-Torrent, C., Shacklett, B. L., Erdtmann, L., Delamarre, L., Bouchaert, I., Sonigo, P., et al. (1999). Interactions of the cytoplasmic domains of human and simian retroviral transmembrane proteins with components of the clathrin adaptor complexes modulate intracellular and cell surface expression of envelope glycoproteins. J. Virol. 73, 1350-1361.
3. Bonavia, A., Bullock, B. T., Gisselman, K. M., Margulies, B. J., and Clements, J. E. (2005). A single amino acid change and truncated TM are sufficient for simian immunodeficiency virus to enter cells using CCR5 in a CD4-independent pathway. Virology 341, 12-23.
4. Derdeyn, C. A., Decker, J. M., Sfakianos, J. N., Wu, X., O'Brien, W. A., Ratner, L., et al. (2000). Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74, 8358-8367.
5. DuBridge, R. B., Tang, P., Hsia, H. C., Leong, P. M., Miller, J. H., and Calos, M. P. (1987). Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7, 379-387.
6. Hatada, M., Yoshimura, K., Harada, S., Kawanami, Y., Shibata, J., and Matsushita, S. (2010). Human immunodeficiency virus type 1 evasion of a neutralizing anti-V3 antibody involves acquisition of a potential glycosylation site in V2. J. Gen. Virol. 91, 1335-1345.
7. Haynes, B. F., Gilbert, P. B., Mcelrath, M. J., Zolla-Pazner, S., Tomaras, G. D., Alam, S. M., et al. (2012). Immune-correlates analysis of an HIV-1 vaccine efficacy trial. N. Engl. J. Med. 366, 1275-1286.
8. Hirsch, V. M., Edmondson, P., Murphey-Corb, M., Arbeille, B., Johnson, P. R., and Mullins, J. I. (1989). SIV adaptation to human cells. Nature 341, 573-574.
9. Kodama, T., Wooley, D. P., Naidu, Y. M., Kestler, H. W. III, Daniel, M. D., Li, Y., et al. (1989). Significance of premature stop codons in env of simian immunodeficiency virus. J. Virol. 63, 4709-4714.
10. Kuwata, T., Katsumata, Y., Takaki, K., Miura, T., and Igarashi, T. (2011). Isolation of potent neutralizing monoclonal antibodies from an SIV-Infected rhesus macaque by phage display. AIDS Res. Hum. Retroviruses 27, 487-500.
11. Kuwata, T., Takaki, K., Yoshimura, K., Enomoto, I., Wu, F., Ourmanov, I., et al. (2013). Conformational epitope consisting of the V3 and V4 loops as a target for potent and broad neutralization of simian immunodeficiency viruses. J. Virol. 87, 5424-5436.
12. Kwong, P. D., and Mascola, J. R. (2012). Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies. Immunity 37, 412-425.
13. LaBranche, C. C., Sauter, M. M., Haggarty, B. S., Vance, P. J., Romano, J., Hart, T. K., et al. (1995). A single amino acid change in the cytoplasmic domain of the simian immunodeficiency virus transmembrane molecule increases envelope glycoprotein expression on infected cells. J. Virol. 69, 5217-5227.
14. Lusso, P., Cocchi, F., Balotta, C., Markham, P. D., Louie, A., Farci, P., et al. (1995). Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1. J. Virol. 69, 3712-3720.
15. Manrique, J. M., Celma, C. C., Affranchino, J. L., Hunter, E., and Gonzalez, S. A. (2001). Small variations in the length of the cytoplasmic domain of the simian immunodeficiency virus transmembrane protein drastically affect envelope incorporation and virus entry. AIDS Res. Hum. Retroviruses 17, 1615-1624.
16. Matsumi, S., Matsushita, S., Yoshimura, K., Javaherian, K., and Takatsuki, K. (1995). Neutralizing monoclonal antibody against a external envelope glycoprotein (gp110) of SIVmac251. AIDS Res. Hum. Retroviruses 11, 501-508.
17. Mori, K., Ringler, D. J., Kodama, T., and Desrosiers, R. C. (1992). Complex determinants of macrophage tropism in env of simian immunodeficiency virus. J. Virol. 66, 2067-2075.
18. Platt, E. J., Wehrly, K., Kuhmann, S. E., Chesebro, B., and Kabat, D. (1998). Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1. J. Virol. 72, 2855-2864.
19. Postler, T. S., and Desrosiers, R. C. (2013). The tale of the long tail: the cytoplasmic domain of HIV-1 gp41. J. Virol. 87, 2-15.
20. Reed, L. J., and Muench, H. (1938). A simple method of estimating fifty per cent endpoints. Am. J. Epidemiol. 27, 493-497.
21. Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., et al. (2009). Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N. Engl. J. Med. 361, 2209-2220.
22. Takeuchi, Y., Mcclure, M. O., and Pizzato, M. (2008). Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. J. Virol. 82, 12585-12588.
23. Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., and Kumar, S. (2011). MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28, 2731-2739.
24. Vzorov, A. N., Gernert, K. M., and Compans, R. W. (2005). Multiple domains of the SIV Env protein determine virus replication efficiency and neutralization sensitivity. Virology 332, 89-101.
25. Vzorov, A. N., Weidmann, A., Kozyr, N. L., Khaoustov, V., Yoffe, B., and Compans, R. W. (2007). Role of the long cytoplasmic domain of the SIV Env glycoprotein in early and late stages of infection. Retrovirology 4, 94.
26. Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., et al. (2002). Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob. Agents Chemother. 46, 1896-1905.
27. Yoshimura, K., Shibata, J., Kimura, T., Honda, A., Maeda, Y., Koito, A., et al. (2006). Resistance profile of a neutralizing anti-HIV monoclonal antibody, KD-247, that shows favourable synergism with anti-CCR5 inhibitors. AIDS 20, 2065-2073.
28. Yusa, K., Maeda, Y., Fujioka, A., Monde, K., and Harada, S. (2005). Isolation of TAK-779-resistant HIV-1 from an R5 HIV-1 GP120 V3 loop library. J. Biol. Chem. 280, 30083-30090.
29. Yuste, E., Johnson, W., Pavlakis, G. N., and Desrosiers, R. C. (2005). Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus. J. Virol. 79, 12455-12463.
30. Yuste, E., Reeves, J. D., Doms, R. W., and Desrosiers, R. C. (2004). Modulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity. J. Virol. 78, 6775-6785.
31. Zhu, P., Chertova, E., Bess, J., Lifson, J. D., Arthur, L. O., Liu, J., et al. (2003). Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions. Proc. Natl. Acad. Sci. U.S.A. 100, 15812-15817.
32. Zhu, P., Liu, J., Bess, J., Chertova, E., Lifson, J. D., Grisé, H., et al. (2006). Distribution and three-dimensional structure of AIDS virus envelope spikes. Nature 441, 847-852.